Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Information Association's New Leadership Outlines Vision Of Group's Future In Asia: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Drug Information Association President Richard Day, the association's new leader, along with DIA Worldwide Executive Director Paul Pomerantz and China Director Steven Basart sat down with PharmAsia News during the Second Annual DIA China meeting in Beijing in May to discuss DIA's strategy and global mission. Day, Executive Director of the Clinical Trials Center in New South Wales, Australia, is the first non-American to run the association, which has offices in the U.S., Switzerland, Japan, India and China.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts